**Financial Highlights:** Clean Science and Technology reported a solid revenue increase of 19% YoY for Q3 FY2025, reaching INR 231.6 Cr. The EBITDA margin improved to 44.8%, reflecting a robust performance bolstered by a favorable product mix.
**Strategic Initiatives and Growth Drivers:** The company incurred approximately INR 160 Cr in capex over 9M FY2025, focusing on its subsidiary, Clean Fino Chem Ltd. Product launches include DHDT and BHT, with significant volume and product diversity growth in HALS.
**Business Developments:** Q3 FY2025 benefitted from new product contributions, helping to enhance overall margins. The board has also approved an interim dividend of INR 2 per share, signaling a positive outlook for shareholder returns.
**Market Position and Competitive Advantage:** Clean Science holds a prominent position as a leading global manufacturer of specialty chemicals, with 64% of revenues generated from exports across 35 countries. The sustained R&D efforts and innovative production processes further strengthen its competitive edge.
**Investor Implications:** The upward trajectory in revenue coupled with solid profitability margins indicates a positive outlook for investors. With continued commitment to green initiatives and expanding international markets, Clean Science presents potential growth opportunities ahead.